A Randomized Clinical Trial to Compare Fleroxacin-Rifampicin with Flucloxacillin or Vancomycin for the Treatment of Staphylococcal Infection
Open Access
- 1 November 2004
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 39 (9), 1285-1292
- https://doi.org/10.1086/424506
Abstract
Background. Oral combination therapy with fluoroquinolones plus rifampicin is a promising alternative to standard parenteral therapy for staphylococcKeywords
This publication has 27 references indexed in Scilit:
- Linezolid versus Vancomycin for the Treatment of Methicillin‐ResistantStaphylococcus aureusInfectionsClinical Infectious Diseases, 2002
- Role of Rifampin for Treatment of Orthopedic Implant–Related Staphylococcal Infections A Randomized Controlled TrialJAMA, 1998
- Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: Prospective randomized comparison with parenteral therapyThe American Journal of Medicine, 1996
- Single-dose pharmacokinetics of oral fleroxacin in bacteremic patientsAntimicrobial Agents and Chemotherapy, 1994
- Influence of rifampin on fleroxacin pharmacokineticsAntimicrobial Agents and Chemotherapy, 1993
- Course and Outcome of Bacteremia Due to Staphylococcus aureus: Evaluation of Different Clinical Case DefinitionsClinical Infectious Diseases, 1993
- Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1991
- TREATMENT OF RIGHT-SIDED STAPHYLOCOCCUS AUREUS ENDOCARDITIS IN INTRAVENOUS DRUG USERS WITH CIPROFLOXACIN AND RIFAMPICINThe Lancet, 1989
- Fluoroquinolone antimicrobial agentsClinical Microbiology Reviews, 1989
- Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humansAntimicrobial Agents and Chemotherapy, 1987